Department of Urology, Eberhard Karls University , Tübingen, Germany .
J Endourol. 2014 Jun;28(6):668-74. doi: 10.1089/end.2013.0755. Epub 2014 Feb 14.
Laparoscopic retroperitoneal lymph node dissection (L-RPLND) is an alternative in patients with metastatic nonseminomatous germcell tumors (NSGCT) necessitating resection of residuals postchemotherapy. With the advancement of laparoscopic vascular surgery, prospective management of the great vessels has become feasible and safe. We present our experience with L-RPLND in NSGCT residuals with significant vascular involvement necessitating intracorporeal reconstruction.
We have retrospectively identified 19 NSGCT patients (mean age 27 years) who presented with residuals postchemotherapy. A bilateral L-RPLND was performed in all men. Infiltration of the great vessels was confirmed intraoperatively. Prospective vascular control and temporary clamping was performed in all cases. The vessel wall was reconstructed using vascular surgery techniques. All patients had at least clinical stages of IIA or higher. Follow-up was obtained in all.
There were no conversions to open surgery. The mean size of the residuals after chemotherapy was 3.87 cm (1.5-9.7 cm). The mean blood loss was 310 mL (50-1000 mL). Mean hospital stay was 6 days (3-9 days). There were no perioperative complications exceeding grade II according to the Clavien-Dindo classification. Distant or in-field recurrence (mean observational period 18 months) did not develop in any patient.
Laparoscopic RPLND may be considered a safe alternative concept for the management of post-chemotherapy NSGCT residuals involving the great vessels. Bilateral L-RPLND in patients with vascular infiltration is feasible and reproducible when laparoscopic vascular surgery can be reliably handled. All standard principles of open surgery are respected, and initial oncologic results are promising.
腹腔镜后腹膜淋巴结清扫术(L-RPLND)是化疗后需要切除残余物的转移性非精原细胞瘤生殖细胞肿瘤(NSGCT)患者的一种替代方法。随着腹腔镜血管外科的进步,对大血管的前瞻性管理变得可行且安全。我们报告了我们在需要腔内重建的有明显血管受累的 NSGCT 残余物中进行 L-RPLND 的经验。
我们回顾性地确定了 19 例化疗后有残余物的 NSGCT 患者(平均年龄 27 岁)。所有男性均行双侧 L-RPLND。术中确认大血管浸润。所有病例均行前瞻性血管控制和临时夹闭。使用血管外科技术重建血管壁。所有患者均至少有 IIA 期或更高的临床分期。所有患者均获得随访。
无中转开放手术。化疗后残余物的平均大小为 3.87cm(1.5-9.7cm)。平均失血量为 310ml(50-1000ml)。平均住院时间为 6 天(3-9 天)。根据 Clavien-Dindo 分类,无术后并发症超过 II 级。任何患者均未出现远处或场内复发(平均观察期 18 个月)。
对于涉及大血管的化疗后 NSGCT 残余物,腹腔镜 RPLND 可能是一种安全的替代治疗方法。当能够可靠地进行腹腔镜血管外科手术时,对于有血管浸润的患者,双侧 L-RPLND 是可行且可重复的。所有开放手术的标准原则都得到了尊重,初步的肿瘤学结果很有希望。